Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Industry Academic Cooperation Foundation Yonsei University has 1 pending office action in the Biotechnology & Pharmaceuticals area. This matter is assigned to a distinct examiner and a distinct art unit. Alexander Marsh Duryee is the busiest examiner with 1 pending office action. With only the pending action, the prosecution is highly concentrated. The outcome of this filing depends on the specific technical interpretations within the art unit and the individual review style of the assigned examiner.
The focus on the distinct examiner and the distinct art unit suggests a narrow technical or procedural scope for the company's current activities at the patent office. Alexander Marsh Duryee is the point of contact for the active matter, requiring the company to tailor its strategy specifically to his past patterns and the specific requirements of that technical group. Practitioners should focus on the specific examiner's history, as his workload represents the company's current interaction with the USPTO in this technology area. Without other pending matters to provide a baseline, the outcome of the 1 pending office action is critical for the portfolio's immediate progress.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DURYEE, ALEXANDER MARSH | 1 | 33.3% | +41.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18590642 | MICROBIOME-BASED COMPOSITION FOR PREVENTING AND TREATING MULTIDRUG-RESISTANT BACTERIAL INFECTIONS | DURYEE, ALEXANDER MARSH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18590642 | MICROBIOME-BASED COMPOSITION FOR PREVENTING AND TREATING MULTIDRUG-RESISTANT BACTERIAL INFECTIONS | DURYEE, ALEXANDER MARSH | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18590642 | MICROBIOME-BASED COMPOSITION FOR PREVENTING AND TREATING MULTIDRUG-RESISTANT BACTERIAL INFECTIONS | DURYEE, ALEXANDER MARSH | 1657 | §101§102§112 | Non-Final OA | — | Pending | Feb 28, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIndustry Academic Cooperation Foundation Yonsei University has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Alexander Marsh Duryee has the most, with 1 of Industry Academic Cooperation Foundation Yonsei University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
